Pharmaceutical market access and planning professionals must make informed global pharmaceutical pricing decisions and negotiate or defend the price that is set. Additionally, they need to continually explore new strategies and opportunities to stay profitable and competitive in a landscape with ever-changing policies.
POLI Strat enables clients to monitor, optimize and establish competitive pharmaceutical pricing, reimbursement, and market access strategies quickly and easily. Our integrated service combines our market leading drug pricing database with headline analysis updates and the insights and analysis of our extensive local experts’ network to provide a holistic view of market dynamics.
POLI Strat provides a complete picture of the history as well as the future of pharma pricing to guide strategy more confidently.
Use our chart functionality to view drug price history alongside headline analysis, indication approval and HTA decisions
Full price history time-series for all three price levels (manufacturer, wholesaler, and retail). Comparison of prices and costs globally to gain insight into broader pricing trends by geography and therapeutic area
We provide an exhaustive intelligence of market events. Headline analysis, monthly bulletin, market access month ahead and regular reports of in-depth analysis
Our solution covers all the nuances of IRP policy, from the reference basket and exchange rates to control of parameters such as pack size and formulation
Quantitative platform assessing risk for access to innovative medicines; developed to benchmark and evaluate stability in market access systems at country level
Granular country pages and profiles for including SWOT, P&R system overview, P&R landscape, reimbursement process, price setting, distribution margins, and P&R policies